Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31662017 | 0.73 | MAPK1 (0.30) | L3MBTL1 | |
| SCHEMBL31662192 | 0.71 | SMN1; SMN2 (0.35) | LMNAL3MBTL1 | |
| SCHEMBL31662449 | 0.70 | — | — | |
| SCHEMBL31661998 | 0.65 | — | — | |
| SCHEMBL31662039 | 0.65 | LMNA (0.31) | LMNAL3MBTL1 | |
| SCHEMBL23908020 | 0.58 | POLB (0.41) | LMNAL3MBTL1 | |
| SCHEMBL31662081 | 0.57 | KMT2A (0.37) | LMNAL3MBTL1 | |
| SCHEMBL21203181 | 0.56 | — | — | |
| SCHEMBL20636583 | 0.56 | — | — | |
| SCHEMBL24738609 | 0.55 | APLNR (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025151594-A1 | FUSED AZINES AS RAS INHIBITORS AND METHODS OF USE THEREOF | KESTREL THERAPEUTICS INC. (US) | 2025-07-17 | — | — | WO | disclosed |